解析接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者抗血小板策略的复杂性 - Suppr

Suppr

超能文献

Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.

作者信息

Sattar Yasar, Elgendy Islam Y

机构信息

Division of Cardiology West Virginia University Morgantown WV USA.

Division of Cardiovascular Medicine Gill Heart Institute, University of Kentucky Lexington KY USA.

出版信息

J Am Heart Assoc. 2024 Oct 15;13(20):e037643. doi: 10.1161/JAHA.124.037643. Epub 2024 Oct 11.

DOI:10.1161/JAHA.124.037643

PMID:39392149

原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC11935590/

Abstract

摘要

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/d8a1/11935590/766e8460f0c7/JAH3-13-e037643-g001.jpg

相似文献

Unraveling the Complexities for Antiplatelet Strategies Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.解析接受经皮冠状动脉介入治疗的急性冠状动脉综合征患者抗血小板策略的复杂性

J Am Heart Assoc. 2024 Oct 15;13(20):e037643. doi: 10.1161/JAHA.124.037643. Epub 2024 Oct 11.

Meta-analysis of duration of dual antiplatelet therapy in patients with acute coronary syndrome after percutaneous coronary intervention.经皮冠状动脉介入治疗后急性冠状动脉综合征患者双联抗血小板治疗持续时间的Meta分析。

Eur J Prev Cardiol. 2019 Mar;26(4):429-432. doi: 10.1177/2047487318795245. Epub 2018 Aug 28.

In-Hospital Outcomes of Dual Loading Antiplatelet Therapy in Patients 75 Years and Older With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: Findings From the CCC-ACS (Improving Care for Cardiovascular Disease in China-Acute Coronary Syndrome) Project.75 岁及以上急性冠状动脉综合征行经皮冠状动脉介入治疗患者双联抗血小板治疗的住院结局：来自 CCC-ACS（改善中国心血管疾病治疗-急性冠状动脉综合征）项目的研究结果。

J Am Heart Assoc. 2018 Mar 30;7(7):e008100. doi: 10.1161/JAHA.117.008100.

Dual antiplatelet therapy dilemmas: duration and choice of antiplatelets in acute coronary syndromes.双联抗血小板治疗的困境：急性冠脉综合征中抗血小板药物的疗程和选择。

Curr Cardiol Rep. 2013 Oct;15(10):405. doi: 10.1007/s11886-013-0405-z.

A randomised trial on platelet function-guided de-escalation of antiplatelet treatment in ACS patients undergoing PCI. Rationale and design of the Testing Responsiveness to Platelet Inhibition on Chronic Antiplatelet Treatment for Acute Coronary Syndromes (TROPICAL-ACS) Trial.一项关于接受经皮冠状动脉介入治疗（PCI）的急性冠状动脉综合征（ACS）患者血小板功能引导下抗血小板治疗降阶梯的随机试验。急性冠状动脉综合征慢性抗血小板治疗中血小板抑制反应性测试（TROPICAL-ACS）试验的原理与设计。

Thromb Haemost. 2017 Jan 5;117(1):188-195. doi: 10.1160/TH16-07-0557. Epub 2016 Sep 22.

Antiplatelet Strategy for Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: A Systematic Review and Network Meta-Analysis.急性冠状动脉综合征行经皮冠状动脉介入治疗患者的抗血小板策略：系统评价和网络荟萃分析。

J Am Heart Assoc. 2024 Oct 15;13(20):e032490. doi: 10.1161/JAHA.122.032490. Epub 2024 Oct 11.

Strategies for Tailored Antiplatelet Therapy after Percutaneous Coronary Intervention: Unraveling Complexities, Embracing Nuances.经皮冠状动脉介入治疗后个性化抗血小板治疗策略：剖析复杂性，把握细微差别。

Thromb Haemost. 2024 May;124(5):497-499. doi: 10.1055/a-2177-4220. Epub 2023 Sep 18.

Double-Dose Versus Standard-Dose Clopidogrel According to Smoking Status Among Patients With Acute Coronary Syndromes Undergoing Percutaneous Coronary Intervention.双重剂量与标准剂量氯吡格雷在经皮冠状动脉介入治疗的急性冠状动脉综合征患者中的应用：吸烟状态的影响。

J Am Heart Assoc. 2017 Nov 3;6(11):e006577. doi: 10.1161/JAHA.117.006577.

Use new antiplatelet therapies consistently in clinical practice.在临床实践中持续使用新型抗血小板疗法。

Cardiovasc J Afr. 2013 Apr;24(3):100.

Clinical Usefulness of PRECISE-DAPT Score for Predicting Bleeding Events in Patients With Acute Coronary Syndrome Undergoing Percutaneous Coronary Intervention: An Analysis From the SMART-DATE Randomized Trial.PRECISE-DAPT 评分预测行经皮冠状动脉介入治疗的急性冠状动脉综合征患者出血事件的临床价值：来自 SMART-DATE 随机试验的分析。

Circ Cardiovasc Interv. 2020 May;13(5):e008530. doi: 10.1161/CIRCINTERVENTIONS.119.008530. Epub 2020 May 1.

本文引用的文献

J Am Heart Assoc. 2024 Oct 15;13(20):e032490. doi: 10.1161/JAHA.122.032490. Epub 2024 Oct 11.

Genetic Testing for Oral P2Y12 Inhibitor Therapy: A Scientific Statement From the American Heart Association.基因检测用于口服 P2Y12 抑制剂治疗：美国心脏协会的科学声明。

Circulation. 2024 Aug 6;150(6):e129-e150. doi: 10.1161/CIR.0000000000001257. Epub 2024 Jun 20.

Ticagrelor monotherapy for acute coronary syndrome: an individual patient data meta-analysis of TICO and T-PASS trials.替格瑞洛单药治疗急性冠脉综合征：TICO 和 T-PASS 试验的个体患者数据分析荟萃分析。

Eur Heart J. 2024 Sep 1;45(33):3045-3056. doi: 10.1093/eurheartj/ehae249.

Ticagrelor or Clopidogrel Monotherapy vs Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Systematic Review and Patient-Level Meta-Analysis.替格瑞洛或氯吡格雷单药治疗与经皮冠状动脉介入治疗后双联抗血小板治疗：系统评价和患者水平荟萃分析。

JAMA Cardiol. 2024 May 1;9(5):437-448. doi: 10.1001/jamacardio.2024.0133.

Navigating the Course of Dual Antiplatelet Therapy After Percutaneous Coronary Intervention: A Review of Guided Approaches.经皮冠状动脉介入治疗后双联抗血小板治疗疗程的探讨：指导性方法综述

Circ Cardiovasc Interv. 2023 Nov 1:e013450. doi: 10.1161/CIRCINTERVENTIONS.123.013450.

2023 ESC Guidelines for the management of acute coronary syndromes.2023年欧洲心脏病学会急性冠状动脉综合征管理指南。

Eur Heart J. 2023 Oct 12;44(38):3720-3826. doi: 10.1093/eurheartj/ehad191.

Comparison of Unguided De-Escalation Versus Guided Selection of Dual Antiplatelet Therapy After Acute Coronary Syndrome: A Systematic Review and Network Meta-Analysis.急性冠状动脉综合征后未引导的降阶梯与有引导的双重抗血小板治疗选择的比较：系统评价和网络荟萃分析。

Circ Cardiovasc Interv. 2022 Aug;15(8):e011990. doi: 10.1161/CIRCINTERVENTIONS.122.011990. Epub 2022 Jul 28.

Comparative effects of guided vs. potent P2Y12 inhibitor therapy in acute coronary syndrome: a network meta-analysis of 61 898 patients from 15 randomized trials.比较指导下与强效 P2Y12 抑制剂治疗急性冠脉综合征的效果：来自 15 项随机试验的 61898 例患者的网络荟萃分析。

Eur Heart J. 2022 Mar 7;43(10):959-967. doi: 10.1093/eurheartj/ehab836.

2021 ACC/AHA/SCAI Guideline for Coronary Artery Revascularization: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines.2021 ACC/AHA/SCAI 冠状动脉血运重建指南：执行摘要：美国心脏病学会/美国心脏协会联合临床实践指南委员会的报告。

Circulation. 2022 Jan 18;145(3):e4-e17. doi: 10.1161/CIR.0000000000001039. Epub 2021 Dec 9.

Mortality after bleeding versus myocardial infarction in coronary artery disease: a systematic review and meta-analysis.冠心病患者出血与心肌梗死的死亡率：系统评价和荟萃分析。

EuroIntervention. 2021 Sep 20;17(7):550-560. doi: 10.4244/EIJ-D-20-01197.

文献AI研究员

20分钟写一篇综述，助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型，支持多种主流文档格式。

立即体验